ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Hemochromatosis
Hemochromatosis in Heart Failure: Clinical Presentation, Diagnosis, and Treatment
ABCHF
Review Article

Hemochromatosis in Heart Failure: Clinical Presentation, Diagnosis, and Treatment

Rodrigo Mantovani Roehrs Sguario et al. Bruno Biselli Luis Fernando Bernal da Costa Seguro

Introduction

Hemochromatosis is a disease characterized by excessive intestinal absorption of iron and its deposition in various organs, including the heart. There are 2 types of hemochromatosis: primary and secondary. Primary or hereditary hemochromatosis (HH) is a genetic disease, whereas secondary hemochromatosis is a consequence of systemic diseases, such as anemia, thalassemia, liver disease, or excessive blood transfusions.

It was first described in the nineteenth century by the French physician Armand Trousseau, who raised the hypothesis that some excess element in the blood was responsible for causing organ damage and skin pigmentation. In 1935, Joseph Sheldon identified that iron accumulation in tissues was responsible for toxicity and was the first to suggest that this metabolic defect had a genetic origin. In the 1950s, a study of iron kinetics correlated increased intestinal iron absorption in patients with hemochromatosis. It was only in 1996 that the “hemochromatosis gene,” HFE (“high Fe”), which is responsible for most cases of the disease, was identified.

[…]

  • cardiomyopathy
  • Heart Failure
  • Hemochromatosis
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
18/11/2024 DOI: 10.36660/abchf.20240041i Views 1

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Sguario RMR, Biselli B, Seguro LFBC. Hemochromatosis in Heart Failure: Clinical Presentation, Diagnosis, and Treatment. ABC Heart Fail Cardiomyop 2024;4(3):e20240041.

Electronic Document Format (ABNT)

Sguario, Rodrigo Mantovani Roehrs; Biselli, Bruno; Seguro, Luis Fernando Bernal da Costa. Hemochromatosis in Heart Failure: Clinical Presentation, Diagnosis, and Treatment. ABC Heart Fail Cardiomyop, v. 4, n. 3, e20240041, Nov. 2024.

Electronic Document Format (APA)

Sguario, R. M. R., Biselli, B., & Seguro, L. F. B. C. (2024). Hemochromatosis in Heart Failure: Clinical Presentation, Diagnosis, and Treatment. ABC Heart Fail Cardiomyop, 4(3), e20240041.

Electronic Document Format (ISO)

Sguario, Rodrigo Mantovani Roehrs and Biselli, Bruno and Seguro, Luis Fernando Bernal da Costa. Hemochromatosis in Heart Failure: Clinical Presentation, Diagnosis, and Treatment. ABC Heart Fail Cardiomyop [online]. 2024, vol. 4, n. 3, [cited 2026-10-14], e20240041. Available from: <https://journals.cardiol.br/en/article/hemochromatosis-in-heart-failure-clinical-presentation-diagnosis-and-treatment/>

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News